Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa K Stamp

Showing results (1-10 of 293) with videos related to

Pageof 30
Sort By:
Current Opinion in Rheumatology|December 8, 2016
Major unanswered questions in the clinical gout fieldLisa K Stamp
Current Opinion in Rheumatology|January 1, 2014
Safety profile of anti-gout agents: an updateLisa K Stamp
The Lancet. Rheumatology|September 7, 2025
Modelling allopurinol-induced severe adverse cutaneous reactionsRebecca Grainger, Lisa K Stamp
Nature Reviews. Rheumatology|December 15, 2018
Prevention and treatment of goutLisa K Stamp, Nicola Dalbeth
The Journal of Rheumatology|April 3, 2010
Is there a role for consensus guidelines for P. jiroveci pneumonia prophylaxis in immunosuppressed patients with rheumatic diseases?Lisa K Stamp, Miriam Hurst
Rheumatology (Oxford, England)|November 8, 2013
Therapeutic drug monitoring in rheumatic diseases: utile or futile?Lisa K Stamp, Murray Barclay
Nature Reviews. Rheumatology|August 16, 2022
Critical appraisal of serum urate targets in the management of goutLisa K Stamp, Nicola Dalbeth
Best Practice & Research. Clinical Rheumatology|November 10, 2021
Treatment advances in goutLisa K Stamp, Hamish Farquhar
Drugs & Aging|August 5, 2011
The challenges of gout management in the elderlyLisa K Stamp, Sarah Jordan
The Journal of Rheumatology|March 15, 2024
What Is Allopurinol Failure and What Should We Do About It?Lisa K Stamp, Nicola Dalbeth
Pageof 30

Showing results (1-10 of 293) with videos related to

Sort By:
Pageof 30
Current Opinion in Rheumatology|December 8, 2016
Major unanswered questions in the clinical gout fieldLisa K Stamp
Current Opinion in Rheumatology|January 1, 2014
Safety profile of anti-gout agents: an updateLisa K Stamp
The Lancet. Rheumatology|September 7, 2025
Modelling allopurinol-induced severe adverse cutaneous reactionsRebecca Grainger, Lisa K Stamp
Nature Reviews. Rheumatology|December 15, 2018
Prevention and treatment of goutLisa K Stamp, Nicola Dalbeth
The Journal of Rheumatology|April 3, 2010
Is there a role for consensus guidelines for P. jiroveci pneumonia prophylaxis in immunosuppressed patients with rheumatic diseases?Lisa K Stamp, Miriam Hurst
Rheumatology (Oxford, England)|November 8, 2013
Therapeutic drug monitoring in rheumatic diseases: utile or futile?Lisa K Stamp, Murray Barclay
Nature Reviews. Rheumatology|August 16, 2022
Critical appraisal of serum urate targets in the management of goutLisa K Stamp, Nicola Dalbeth
Best Practice & Research. Clinical Rheumatology|November 10, 2021
Treatment advances in goutLisa K Stamp, Hamish Farquhar
Drugs & Aging|August 5, 2011
The challenges of gout management in the elderlyLisa K Stamp, Sarah Jordan
The Journal of Rheumatology|March 15, 2024
What Is Allopurinol Failure and What Should We Do About It?Lisa K Stamp, Nicola Dalbeth
Pageof 30